Evolving Therapies and FAK Inhibitors for the Treatment of Cancer

E-ISSN： 1875-5992|10|10|722-734

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.10, 2010-12, pp. : 722-734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer

By Fakih Marwan

Expert Review of Anticancer Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 427-438

Informa Healthcare

Access to resources Recommend Favorite

Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer

Current Cancer Therapy Reviews, Vol. 10, Iss. 4, 2014-11 ,pp. : 353-359

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer treatment: the combination of vaccination with other therapies

By Andersen Mads Sørensen Rikke Schrama David Svane Inge Becker Jürgen thor Straten Per

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1735-1743

Springer Publishing Company

Access to resources Recommend Favorite

Membrane Receptor and Antiangiogenic Targeted Therapies in the Treatment of Cancer

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 51-61

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors in the treatment of cancer

By Brown Peter

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 1-10

Humana Press, Inc

Access to resources Recommend Favorite